Our data suggest that the enhanced activation of p70S6K by HGF might compensate for the loss of cell division in abemaciclib-treated cells and thus contribute to abemaciclib resistance in metastatic UM melanoma cells. The gene discussed is RPS6KB1; the disease is melanoma.